Mirati Therapeutics
MRTX
#2965
Rank
NZ$6.90 B
Marketcap
$98.43
Share price
0.00%
Change (1 day)
48.35%
Change (1 year)

EPS for Mirati Therapeutics (MRTX)

EPS in 2023 (TTM): -$20.99

According to Mirati Therapeutics's latest financial reports the company's current EPS (TTM) is -$21.50. In 2022 the company made an earnings per share (EPS) of -$22.10 a decrease over its 2021 EPS that were of -$18.73.

EPS history for Mirati Therapeutics from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$20.99-5.02%
2022-$22.1017.99%
2021-$18.7340.5%
2020-$13.3340.96%
2019-$9.4677.92%
2018-$5.3213.62%
2017-$4.68-33.57%
2016-$7.0410.82%
2015-$6.3616.98%
2014-$5.43-32.19%
2013-$8.0168.77%
2012-$4.75-15.95%
2011-$5.65-81.27%
2010-$30.15-37.19%
2009-$48.00174.53%
2008-$17.49-65.27%
2007-$50.35146.72%
2006-$20.41-58.81%
2005-$49.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$15.96-174.26%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.10-99.53% Bahamas